ERBB2 and breast carcinoma: ERBB2 (Erb-B2 Receptor Tyrosine Kinase 2, also known as HER2) is one of the most studied oncogenes, being considered a breast cancer biomarker (at the gene and protein levels), commonly overexpressed in HBC [6].